在移植中,基于阿莱姆图祖马布的诱导治疗与基于巴西力西马布的诱导治疗 (3C研究):一项随机试验
Lancet (London, England)
|August 1, 2014
概括
与巴西力西马布相比,基于阿莱姆图祖马布的诱导疗法显著减少了移植患者的急性排斥. 这种方法涉及减少氨酸抑制剂和酸暴露以及避免使用类固醇,有望改善移植结果.
科学领域:
- 腎病學和免疫學 腎病學和免疫學
- 移植医学 移植医学
- 临床试验和治疗方法
背景情况:
- 氨酸抑制剂 (CNIs) 对于短期的移植成功至关重要,但可能会增加长期的衰竭风险.
- 移植后的阿勒姆图祖马布诱导,其次是降低免疫抑制和避开类固醇的疗效仍然不确定.
- 这项研究探讨了阿莱姆图祖马布与巴西力西马布诱导策略在移植中的比较有效性.
研究的目的:
- 评估基于阿勒姆图祖马布的诱导疗法的疗效和安全性,与基于巴西利克西马布的诱导疗法相比,在脏移植接受者中.
- 评估阿勒姆图祖马布诱导对活检证明的急性排斥率在移植后六个月的影响.
主要方法:
- 这是一项随机对照试验,涉及18个英国中心的852名成年移植接受者.
- 患者被随机分配 (1:1) 接受降低免疫抑制的阿莱姆图祖马布 (tacrolimus,mycophenolate,没有类固醇) 或标准免疫抑制的巴西利西马布 (tacrolimus,mycophenolate,prednisolone) 诱导.
- 主要终点是六个月内经过活检证明的急性排斥,通过治疗意图进行分析.
主要成果:
- 与巴西力西马布相比,基于阿莱姆图祖马布的治疗导致活检证明的急性排斥减少了58% (7%与16%,HR 0.42,p<0.0001).
- 在六个月内移植失败 (p=0.58) 或严重感染 (p=0.88) 方面,研究小组之间没有发现显著差异.
- 六个月内死亡率略高于阿莱姆图祖马布组 (3%对1%,HR1.79,p=0.25),但在统计学上并不显著.
结论:
- 阿拉姆图祖马布的诱导疗法,加上减少氨氨酸抑制剂/氨酸和避免使用类固醇,显著降低了移植患者急性排斥的风险.
- 这些发现表明,阿勒姆图祖马布在预防早期排斥发作方面具有潜在的益处.
- 需要长期跟踪,以确定这些早期好处是否转化为改善长期移植功能和患者存活率.
相关概念视频
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...


